4399免费视频

山(shan)東(dong)(dong)泰(tai)邦(bang)生(sheng)(sheng)(sheng)物(wu)(wu)制(zhi)品(pin)(pin)(pin)(pin)有(you)(you)限(xian)(xian)公(gong)(gong)司(si)(si)(si)簡介山(shan)東(dong)(dong)泰(tai)邦(bang)生(sheng)(sheng)(sheng)物(wu)(wu)制(zhi)品(pin)(pin)(pin)(pin)有(you)(you)限(xian)(xian)公(gong)(gong)司(si)(si)(si)是(shi)在(zai)(zai)山(shan)東(dong)(dong)省生(sheng)(sheng)(sheng)物(wu)(wu)制(zhi)品(pin)(pin)(pin)(pin)研(yan)(yan)究所(suo)與(yu)外(wai)商于(yu)二(er)(er)00二(er)(er)年(nian)(nian)(nian)十一(yi)(yi)月成立(li)的(de)合(he)資(zi)企(qi)業(ye)(ye)(ye)。是(shi)以(yi)(yi)血液(ye)(ye)制(zhi)品(pin)(pin)(pin)(pin)、基因工(gong)程(cheng)產品(pin)(pin)(pin)(pin)和生(sheng)(sheng)(sheng)化(hua)(hua)制(zhi)藥為(wei)(wei)主體(ti)的(de),集科(ke)研(yan)(yan)、生(sheng)(sheng)(sheng)產、經(jing)營一(yi)(yi)體(ti)化(hua)(hua)的(de)重點(dian)高新(xin)技(ji)術企(qi)業(ye)(ye)(ye)。是(shi)山(shan)東(dong)(dong)定(ding)點(dian)的(de)國(guo)家血液(ye)(ye)制(zhi)品(pin)(pin)(pin)(pin)生(sheng)(sheng)(sheng)產企(qi)業(ye)(ye)(ye)。公(gong)(gong)司(si)(si)(si)總部(bu)設在(zai)(zai)山(shan)東(dong)(dong)泰(tai)安。在(zai)(zai)泰(tai)安建有(you)(you)一(yi)(yi)個(ge)(ge)血液(ye)(ye)制(zhi)品(pin)(pin)(pin)(pin)生(sheng)(sheng)(sheng)產基地(di)和血液(ye)(ye)制(zhi)品(pin)(pin)(pin)(pin)研(yan)(yan)究中(zhong)心(xin)。公(gong)(gong)司(si)(si)(si)現有(you)(you)人(ren)(ren)(ren)血白蛋(dan)(dan)白、人(ren)(ren)(ren)免(mian)疫(yi)球蛋(dan)(dan)白、靜注人(ren)(ren)(ren)免(mian)疫(yi)球蛋(dan)(dan)白（pH4）、乙型肝炎人(ren)(ren)(ren)免(mian)疫(yi)球蛋(dan)(dan)白、狂犬病(bing)人(ren)(ren)(ren)免(mian)疫(yi)球蛋(dan)(dan)白、破傷(shang)風人(ren)(ren)(ren)免(mian)疫(yi)球蛋(dan)(dan)白、人(ren)(ren)(ren)凝(ning)血因子(zi)Ⅷ、人(ren)(ren)(ren)凝(ning)血酶原復(fu)合(he)物(wu)(wu)、人(ren)(ren)(ren)纖維蛋(dan)(dan)白原等9個(ge)(ge)品(pin)(pin)(pin)(pin)種，24個(ge)(ge)規格(ge)的(de)產品(pin)(pin)(pin)(pin)，產品(pin)(pin)(pin)(pin)批簽發(fa)合(he)格(ge)率100%，優質的(de)產品(pin)(pin)(pin)(pin)贏得(de)了市(shi)場的(de)青睞。合(he)資(zi)以(yi)(yi)來(lai)，銷售收入年(nian)(nian)(nian)增長率超(chao)過50%。泰(tai)邦(bang)生(sheng)(sheng)(sheng)物(wu)(wu)成立(li)六年(nian)(nian)(nian)來(lai),生(sheng)(sheng)(sheng)產經(jing)營迅速擴(kuo)大,經(jing)濟取得(de)長足發(fa)展(zhan)。企(qi)業(ye)(ye)(ye)的(de)綜合(he)實力從最(zui)初的(de)血液(ye)(ye)制(zhi)品(pin)(pin)(pin)(pin)行(xing)業(ye)(ye)(ye)第(di)(di)三梯隊上(shang)升為(wei)(wei)第(di)(di)一(yi)(yi)梯隊，產值(zhi)利潤等各項經(jing)濟指標統計的(de)綜合(he)實力排名,去年(nian)(nian)(nian)居全國(guo)血液(ye)(ye)制(zhi)品(pin)(pin)(pin)(pin)同行(xing)業(ye)(ye)(ye)位列前(qian)(qian)3位。目前(qian)(qian)，公(gong)(gong)司(si)(si)(si)擁有(you)(you)一(yi)(yi)支國(guo)際化(hua)(hua)的(de)管理(li)團隊，其中(zhong)境外(wai)高管人(ren)(ren)(ren)士(shi)近半數，建立(li)起了與(yu)國(guo)際化(hua)(hua)運(yun)作相適應的(de)管理(li)隊伍。2009年(nian)(nian)(nian)12月公(gong)(gong)司(si)(si)(si)控股股東(dong)(dong)—China Biologic Products, Inc.（中(zhong)國(guo)生(sheng)(sheng)(sheng)物(wu)(wu)制(zhi)品(pin)(pin)(pin)(pin)）于(yu)美國(guo)納斯達(da)克成功上(shang)市(shi)（交易代碼為(wei)(wei)NASDAQ:CBPO），為(wei)(wei)公(gong)(gong)司(si)(si)(si)的(de)發(fa)展(zhan)提(ti)供了強大的(de)資(zi)本支持， 2009年(nian)(nian)(nian)9月，中(zhong)國(guo)生(sheng)(sheng)(sheng)物(wu)(wu)制(zhi)品(pin)(pin)(pin)(pin)從12000多家候選上(shang)市(shi)公(gong)(gong)司(si)(si)(si)中(zhong)脫穎而出，榮登《福布斯》公(gong)(gong)布2009亞洲200家中(zhong)小企(qi)業(ye)(ye)(ye)榜單。